Sakar Healthcare Limited

₹975.55As of Sun 8 Nov 2026, 12:00 UTC
NSE:SAKARHealthcare
Country India
PE (Fwd) •••
TSR 9Y CAGR 36.27%
Div yield —
ROE 13.20%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.45
PE TTM 50.48
TSR TTM 170.09%
Mkt cap ₹21.71B
ROIC 11.89%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹1,146
17.43%
(86.08%)
Hold 6|12|7|3|10
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
20.78
21.62
20.67
21.67
13.07%
14.41%
11.61%
12.88%
Revenue₹B
1.509
1.502
1.583
1.588
7.14%
4.34%
10.02%
4.60%
Peers (US$231.0M)
Cap (US$)
PE
213.2M
14.37x
Capital
TTM
5Y
10Y
Leveragex
1.148
(0.109)
(0.098)
EBIT/Intx
0.437
1.082
0.871
Own earn%
33.66
(13.81)
(7.05)
Sh yield%
41.56
31.32
31.67
Owners
Insiders/Inst%
2.75
22.21
Short interest%
3.15
SBC / revenue%
5.69
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
8
Op margin range%
5–16
$1 testx
−0.1
Incr. ROIC%
6